-
1
-
-
0019513248
-
Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis
-
Sirtori CR, Gianfranceschi G, Sirtori M, et al. Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis 1981;38: 267-271
-
(1981)
Atherosclerosis
, vol.38
, pp. 267-271
-
-
Sirtori, C.R.1
Gianfranceschi, G.2
Sirtori, M.3
-
2
-
-
0023840497
-
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia
-
Taskinen MR, Nikkilä EA. Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia. Atherosclerosis 1988;69: 249-255
-
(1988)
Atherosclerosis
, vol.69
, pp. 249-255
-
-
Taskinen, M.R.1
Nikkilä, E.A.2
-
3
-
-
33644695097
-
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients
-
Bajaj M, Suraamornkul S, Romanelli A, et al. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005;54: 3148-3153
-
(2005)
Diabetes
, vol.54
, pp. 3148-3153
-
-
Bajaj, M.1
Suraamornkul, S.2
Romanelli, A.3
-
4
-
-
33847347318
-
Paradoxical changes in muscle gene expression in insulinresistant subjects after sustained reduction in plasma free fatty acid concentration
-
Bajaj M, Medina-Navarro R, Suraamornkul S, Meyer C, DeFronzo RA, Mandarino LJ. Paradoxical changes in muscle gene expression in insulinresistant subjects after sustained reduction in plasma free fatty acid concentration. Diabetes 2007;56: 743-752
-
(2007)
Diabetes
, vol.56
, pp. 743-752
-
-
Bajaj, M.1
Medina-Navarro, R.2
Suraamornkul, S.3
Meyer, C.4
DeFronzo, R.A.5
Mandarino, L.J.6
-
5
-
-
84894564179
-
Reduction of nonesterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: A randomised clinical trial
-
Phielix E, Jelenik T, Nowotny P, Szendroedi J, Roden M. Reduction of nonesterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: A randomised clinical trial. Diabetologia 2014;57: 572-581
-
(2014)
Diabetologia
, vol.57
, pp. 572-581
-
-
Phielix, E.1
Jelenik, T.2
Nowotny, P.3
Szendroedi, J.4
Roden, M.5
-
7
-
-
58149346025
-
Lower intrinsic ADPstimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients
-
Phielix E, Schrauwen-Hinderling VB, Mensink M, et al. Lower intrinsic ADPstimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008;57: 2943-2949
-
(2008)
Diabetes
, vol.57
, pp. 2943-2949
-
-
Phielix, E.1
Schrauwen-Hinderling, V.B.2
Mensink, M.3
-
8
-
-
0036788293
-
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
-
Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51: 2944-2950
-
(2002)
Diabetes
, vol.51
, pp. 2944-2950
-
-
Kelley, D.E.1
He, J.2
Menshikova, E.V.3
Ritov, V.B.4
-
9
-
-
34249681435
-
Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes
-
Szendroedi J, Schmid AI, Chmelik M, et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007;4: E154
-
(2007)
PLoS Med
, vol.4
, pp. e154
-
-
Szendroedi, J.1
Schmid, A.I.2
Chmelik, M.3
-
10
-
-
0028203880
-
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period
-
Worm D, Henriksen JE, Vaag A, Thye-Rønn P, Melander A, Beck-Nielsen H. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 1994;78: 717-721
-
(1994)
J Clin Endocrinol Metab
, vol.78
, pp. 717-721
-
-
Worm, D.1
Henriksen, J.E.2
Vaag, A.3
Thye-Rønn, P.4
Melander, A.5
Beck-Nielsen, H.6
-
11
-
-
0027493805
-
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM
-
Saloranta C, Taskinen MR, Widen E, Härkönen M, Melander A, Groop L. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 1993;42: 1559-1566
-
(1993)
Diabetes
, vol.42
, pp. 1559-1566
-
-
Saloranta, C.1
Taskinen, M.R.2
Widen, E.3
Härkönen, M.4
Melander, A.5
Groop, L.6
-
12
-
-
50949120914
-
Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor Vitamins in human nutrition
-
Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor Vitamins in human nutrition. Annu Rev Nutr 2008;28: 115-130
-
(2008)
Annu Rev Nutr
, vol.28
, pp. 115-130
-
-
Bogan, K.L.1
Brenner, C.2
-
13
-
-
84862022077
-
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity
-
Cantó C, Houtkooper RH, Pirinen E, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity. Cell Metab 2012;15: 838-847
-
(2012)
Cell Metab
, vol.15
, pp. 838-847
-
-
Cantó, C.1
Houtkooper, R.H.2
Pirinen, E.3
-
14
-
-
84880517634
-
The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling
-
Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013;154: 430-441
-
(2013)
Cell
, vol.154
, pp. 430-441
-
-
Mouchiroud, L.1
Houtkooper, R.H.2
Moullan, N.3
-
15
-
-
80053920774
-
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice
-
Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab 2011;14: 528-536
-
(2011)
Cell Metab
, vol.14
, pp. 528-536
-
-
Yoshino, J.1
Mills, K.F.2
Yoon, M.J.3
Imai, S.4
-
16
-
-
31044448925
-
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing
-
Benyó Z, Gille A, Kero J, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005;115: 3634-3640
-
(2005)
J Clin Invest
, vol.115
, pp. 3634-3640
-
-
Benyó, Z.1
Gille, A.2
Kero, J.3
-
17
-
-
0022261250
-
Variability of aerobic performance in the laboratory and its physiologic correlates
-
Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G. Variability of aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med 1985;6: 197-201
-
(1985)
Int J Sports Med
, vol.6
, pp. 197-201
-
-
Kuipers, H.1
Verstappen, F.T.2
Keizer, H.A.3
Geurten, P.4
Van Kranenburg, G.5
-
18
-
-
77049310862
-
The gross composition of the body
-
Siri WE. The gross composition of the body. Adv Biol Med Phys 1956;4: 239-280
-
(1956)
Adv Biol Med Phys
, vol.4
, pp. 239-280
-
-
Siri, W.E.1
-
19
-
-
0018520840
-
Glucose clamp technique: A method for quantifying insulin secretion and resistance
-
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-E223
-
(1979)
Am J Physiol
, vol.237
, pp. E214-E223
-
-
DeFronzo, R.A.1
Tobin, J.D.2
Andres, R.3
-
20
-
-
0035514950
-
Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes
-
Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001;50: 2548-2554
-
(2001)
Diabetes
, vol.50
, pp. 2548-2554
-
-
Mensink, M.1
Blaak, E.E.2
Van Baak, M.A.3
Wagenmakers, A.J.4
Saris, W.H.5
-
21
-
-
33644746318
-
Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
-
Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhäusl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006;55: 136-140
-
(2006)
Diabetes
, vol.55
, pp. 136-140
-
-
Brehm, A.1
Krssak, M.2
Schmid, A.I.3
Nowotny, P.4
Waldhäusl, W.5
Roden, M.6
-
22
-
-
0020576146
-
Calculation of substrate oxidation rates in vivo from gaseous exchange
-
Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55: 628-634
-
(1983)
J Appl Physiol
, vol.55
, pp. 628-634
-
-
Frayn, K.N.1
-
23
-
-
0014141311
-
Diet, muscle glycogen and physical performance
-
Bergström J, Hermansen L, Hultman E, Saltin B. Diet, muscle glycogen and physical performance. Acta Physiol Scand 1967;71: 140-150
-
(1967)
Acta Physiol Scand
, vol.71
, pp. 140-150
-
-
Bergström, J.1
Hermansen, L.2
Hultman, E.3
Saltin, B.4
-
24
-
-
0034940413
-
Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids
-
Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 2001;116: 63-68
-
(2001)
Histochem Cell Biol
, vol.116
, pp. 63-68
-
-
Koopman, R.1
Schaart, G.2
Hesselink, M.K.3
-
25
-
-
84878138385
-
Mitonuclear protein imbalance as a conserved longevity mechanism
-
Houtkooper RH, Mouchiroud L, Ryu D, et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 2013;497: 451-457
-
(2013)
Nature
, vol.497
, pp. 451-457
-
-
Houtkooper, R.H.1
Mouchiroud, L.2
Ryu, D.3
-
26
-
-
27344435774
-
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
-
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102: 15545-15550
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
-
27
-
-
84865731753
-
The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease
-
Bai P, Cantó C. The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab 2012;16: 290-295
-
(2012)
Cell Metab
, vol.16
, pp. 290-295
-
-
Bai, P.1
Cantó, C.2
-
28
-
-
79953761260
-
PARP-2 regulates SIRT1 expression and whole-body energy expenditure
-
Bai P, Canto C, Brunyánszki A, et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 2011;13: 450-460
-
(2011)
Cell Metab
, vol.13
, pp. 450-460
-
-
Bai, P.1
Canto, C.2
Brunyánszki, A.3
-
29
-
-
67349276169
-
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
-
Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009;458: 1056-1060
-
(2009)
Nature
, vol.458
, pp. 1056-1060
-
-
Cantó, C.1
Gerhart-Hines, Z.2
Feige, J.N.3
-
30
-
-
65549103855
-
Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis
-
Ramsey KM, Yoshino J, Brace CS, et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009;324: 651-654
-
(2009)
Science
, vol.324
, pp. 651-654
-
-
Ramsey, K.M.1
Yoshino, J.2
Brace, C.S.3
-
31
-
-
0035121962
-
Lipid-dependent control of hepatic glycogen stores in healthy humans
-
Stingl H, Krssák M, Krebs M, et al. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 2001;44: 48-54
-
(2001)
Diabetologia
, vol.44
, pp. 48-54
-
-
Stingl, H.1
Krssák, M.2
Krebs, M.3
-
32
-
-
0000648085
-
Influences of glucose loading and of injected insulin on hepatic glucose output
-
Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959;82: 420-430
-
(1959)
Ann N Y Acad Sci
, vol.82
, pp. 420-430
-
-
Steele, R.1
-
33
-
-
0027491783
-
Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes
-
Saloranta C, Groop L, Ekstrand A, Franssila-Kallunki A, Eriksson J, Taskinen MR. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes. Diabet Med 1993;10: 950-957
-
(1993)
Diabet Med
, vol.10
, pp. 950-957
-
-
Saloranta, C.1
Groop, L.2
Ekstrand, A.3
Franssila-Kallunki, A.4
Eriksson, J.5
Taskinen, M.R.6
-
34
-
-
0029948212
-
Mechanism of free fatty acid-induced insulin resistance in humans
-
Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97: 2859-2865
-
(1996)
J Clin Invest
, vol.97
, pp. 2859-2865
-
-
Roden, M.1
Price, T.B.2
Perseghin, G.3
-
35
-
-
84902270555
-
Pharmacological Inhibition of poly(ADPribose) polymerases improves fitness and mitochondrial function in skeletal muscle
-
Pirinen E, Cantó C, Jo YS, et al. Pharmacological Inhibition of poly(ADPribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab 2014;19: 1034-1041
-
(2014)
Cell Metab
, vol.19
, pp. 1034-1041
-
-
Pirinen, E.1
Cantó, C.2
Jo, Y.S.3
-
36
-
-
0024244339
-
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM
-
Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37: 1020-1024
-
(1988)
Diabetes
, vol.37
, pp. 1020-1024
-
-
Reaven, G.M.1
Hollenbeck, C.2
Jeng, C.Y.3
Wu, M.S.4
Chen, Y.D.5
-
37
-
-
0024204528
-
The dawn phenomenon: Its origin and contribution to early morning hyperglycemia in diabetes mellitus
-
Bolli GB. The dawn phenomenon: Its origin and contribution to early morning hyperglycemia in diabetes mellitus. Diabete Metab 1988;14: 675-686
-
(1988)
Diabete Metab
, vol.14
, pp. 675-686
-
-
Bolli, G.B.1
-
38
-
-
0025760006
-
Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes
-
Shapiro ET, Polonsky KS, Copinschi G, et al. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. J Clin Endocrinol Metab 1991;72: 444-454
-
(1991)
J Clin Endocrinol Metab
, vol.72
, pp. 444-454
-
-
Shapiro, E.T.1
Polonsky, K.S.2
Copinschi, G.3
-
39
-
-
33748485573
-
Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: Acute effect of fatty acids
-
Hoeks J, Hesselink MK, Russell AP, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: Acute effect of fatty acids. Diabetologia 2006;49: 2419-2426
-
(2006)
Diabetologia
, vol.49
, pp. 2419-2426
-
-
Hoeks, J.1
Hesselink, M.K.2
Russell, A.P.3
-
40
-
-
77956367951
-
Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance
-
Hoeks J, van Herpen NA, Mensink M, et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010;59: 2117-2125
-
(2010)
Diabetes
, vol.59
, pp. 2117-2125
-
-
Hoeks, J.1
Van Herpen, N.A.2
Mensink, M.3
-
41
-
-
33645526333
-
Effect of 6-month calorie restriction on biomarkers of longevity metabolic adaptation and oxidative stress in overweight individuals: A randomized controlled trial
-
Pennington CALERIE Team
-
Heilbronn LK, de Jonge L, Frisard MI, et al.; Pennington CALERIE Team. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial. JAMA 2006;295: 1539-1548
-
(2006)
JAMA
, vol.295
, pp. 1539-1548
-
-
Heilbronn, L.K.1
De Jonge, L.2
Frisard, M.I.3
-
42
-
-
77950349827
-
Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity
-
Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 2010;59: 572-579
-
(2010)
Diabetes
, vol.59
, pp. 572-579
-
-
Meex, R.C.1
Schrauwen-Hinderling, V.B.2
Moonen-Kornips, E.3
-
43
-
-
80455143206
-
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans
-
Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011;14: 612-622
-
(2011)
Cell Metab
, vol.14
, pp. 612-622
-
-
Timmers, S.1
Konings, E.2
Bilet, L.3
|